Table 2 IDH study summary data: summary of the analysis of 19 IDH patients

Total enrolled

n = 60*

HTLV-1 +

n = 33

IDH confirmed

n = 19

HTLV-1/HIV +

n = 9

(of n = 33)

Ethnicity

all black african

HTLV-1 subtype

Cosmopolitan (1a)

Age

mean

8 years

range

8 months −15 years (IQR 7–11)

Gender distribution

male

68.40%

female

52.60%

Microbiology

Staph Aureus

55.60%

Streptococcal spp

33.60%

Clinical examination

dermatological

scalp (78.9%) and axilla (73.7%) commonest sites of involvement

neurological

no evidence for HAM/TSP

opthalmological

corneal opacities 3(15.6%)

Immunologic parameters

mean (normals) g/l

IgA

3.52 (0.65-2.9)

IgG

22.6 (5.2-15.6)

IgM

1.38 (0.28-2.4)

SPEP

mean (normals) g/l

Albumin

32.5 (32–50)

Alpha 1 globulin

4.0 (1.72-3.30)

Alpha 2 globulin

11.1 (4.2-8.7)

Beta globulin

11.4 (5.2-10.5)

Gamma globulin

26.7 (7.1-14.5)

Blood counts

mean (normals)

Hb

12.3 (11.5-13.5) g/dl

WBCC

10.1 (4-11x10^9)

Platelets

405 (150-450x10^9)

ESR

40 (3–9 mm/hr)

CD4 count

1958 (500–1500) cells/mm3

CD8 count

1150 (436–2278) cells/mm3

CD4 : CD8 ratio

1.7:1

HTLV-1 proviral load

mean (range%)

10.5 (1.8-29.8)